Results 141 to 150 of about 500 (180)

Exploring the heterogeneity of hepatic and pancreatic fat deposition in obesity: implications for metabolic health. [PDF]

open access: yesFront Endocrinol (Lausanne)
Deng M   +9 more
europepmc   +1 more source

Wound-healing and onboard care during long-duration human deep space exploration from a surgical perspective through the lens of a scoping review. [PDF]

open access: yesJ Vasc Surg Venous Lymphat Disord
Babocs D   +6 more
europepmc   +1 more source

Venous Leg Ulcer: A Meta-analysis of Adjunctive Therapy with Micronized Purified Flavonoid Fraction [PDF]

open access: yesEuropean Journal of Vascular and Endovascular Surgery, 2005
ObjectiveTo assess the effect of oral treatment with micronized purified flavonoid fraction (MPFF) on leg ulcer healing.DesignMeta-analysis of randomised prospective studies using MPFF in addition to conventional treatment.Materials and methodsFive ...
C Lok, A -A Ramelet
exaly   +2 more sources

MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial

International Angiology, 2023
The efficacy and tolerability of the new micronized purified flavonoid fraction (MPFF) 1000 mg once-daily chewable formulation in comparison with the established MPFF 500 mg conventional tablet at the same daily dose are unknown.CHEWY was an international, multicenter, double-blind, double-dummy, randomized, parallel group, non-inferiority phase III ...
Armando, Mansilha   +5 more
openaire   +2 more sources

Clinical Efficacy of Micronized Purified Flavonoid Fraction (MPFF) in Edema

Angiology, 2000
Swelling is one of the most frequent complaints of patients in daily clinical practice; leg edema is its objective confirmation. It can be associated with several diseases. Micronized purified flavonoid fraction (MPFF) is a phlebotropic drug commonly used to treat the signs and symptoms associated with chronic venous insufficiency (CVI).
exaly   +3 more sources

The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease [PDF]

open access: yesAdvances in Therapy, 2020
At the 2019 European Venous Forum in Zurich Switzerland, a symposium entitled "State of the art: benefits of MPFF throughout CVD progression" was held to discuss the developing treatment strategies for patients at all stages of chronic venous disease (CVD).
exaly   +3 more sources

Beneficial effect of MPFF administration on the healing process of venous ulcer

Hellenic Journal of Surgery, 2017
Venous hypertension underlies all clinical manifestations of chronic venous insufficiency (CVI). It is transmitted to the microcirculation and results in capillary changes which lead to edema, skin damage and eventually venous ulceration. The venoactive drugs are believed to have a therapeutic effect in venous disorders. This study evaluated the effect
Konstantina K. Katseni   +2 more
openaire   +1 more source

[Efficacy and safety of micronized purified flavonoid fraction (MPFF) in treatment of venous diseases in geriatric patients].

Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery, 2019
Analysed herein is the experience with micronized purified flavonoid fraction (MPFF) in treatment of geriatric patients with decompensated forms of chronic venous diseases. A total of 218 geriatric patients were examined and treated. Of these, 132 patients had trophic disorders (C4-C6 class), including 40 patients found to have venous trophic ulcers ...
Viktor G. Gudymovich
exaly   +3 more sources

Home - About - Disclaimer - Privacy